The medical impact of hepatitis D virus infection in Uzbekistan-Reference-Cited by-同舟云学术

The medical impact of hepatitis D virus infection in Uzbekistan

Published:2019-09-20 Issue:11 Volume:39 Page:2077-2081
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Khodjaeva Malika¹,Ibadullaeva Nargiz¹,Khikmatullaeva Aziza¹,Joldasova Elizaveta¹,Ismoilov Umed²,Colombo Massimo³,Caviglia Gian Paolo⁴,Rizzetto Mario⁴^ORCID,Musabaev Erkin¹

Affiliation:

1. Research Institute of Virology Tashkent Uzbekistan

2. Hepatology Center Institute of Virology Tashkent Uzbekistan

3. Clinical and Research Center Humanitas Hospital Rozzano Italy

4. Department of Medical Sciences University of Torino Turin Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14243

Reference25 articles.

1. Hepatitis D virus infection; Iran, Middle East and Central Asia;Alavian SM;Hepat Mon,2005

2. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan

3. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians

4. Prognostic marker of liver fibrosis in patients with chronic viral hepatitis B and D;Abdukadirova M;European J Biomed Pharm Sci,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Years of potential life lost due to hepatitis B with or without Delta agent in the Kyrgyz Republic;Russian Journal of Infection and Immunity;2024-08-05

2. The distinct spatiotemporal evolutionary landscape of HBV and HDV largely determines the unique epidemic features of HDV globally;Molecular Phylogenetics and Evolution;2024-08

3. What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?;Clinics in Liver Disease;2023-11

4. Elimination of HDV: Epidemiologic implications and public health perspectives;Liver International;2023-04-21

5. Hepatitis delta: Epidemiology to recent advances in therapeutic agents;Hepatology;2023-02-06